Teladoc Health ( NYSE: TDOC ) shares traded in the green on Thursday, snapping six consecutive days of losses. The stock closed up 0.70% at $7.

21. TDOC stock fell about 72% in the last 12 months. YTD, the stock is trading down 67%, compared to the broader S&P 500 market which is up 9.

01%. Looking at Seeking Alpha's Quant Ratings, this company has a Strong Sell rating with a score of 1.35 out of 5.

When it comes to Wall Street analysis, 21 out of 27 analysts recommend a Hold, 3 recommend a Buy and 3 recommend a Strong Buy. According to Juxtaposed Ideas, “Teladoc's new management has delivered a painful FQ2'24 earnings call, as observed in the BetterHelp impairment costs and withdrawn forward guidance.It is apparent that the telehealth company is facing growth issues and elevated marketing/advertising costs, with its near-term prospects likely to remain underwhelming.

Combined with the potential price decline to penny stock levels, we believe that it may be more prudent to observe the TDOC stock's movement, while waiting for further clarity in its near-term execution.” Seeking Alpha analysts have a Hold rating on the company..